PRPL / Purple Innovation, Inc. - تصريحات هيئة الأوراق المالية والبورصات، التقرير السنوي، بيان الوكيل

Amendment to Amended and Restated Employment Agreement

Exhibit 10.1 Amendment to Amended and Restated Employment Agreement This Amendment to Amended and Restated Employment Agreement (this “Amendment”) is hereby entered into as of August 7, 2025 by and between Purple Innovation, Inc. (the “Company”) and Robert T. DeMartini (“you”), and constitutes an amendment to your Amended and Restated Employment Agreement with the Company dated March 19, 2022, as

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2025 Purple Innovation,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2025 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Empl

Amendment to Restricted Share Unit Agreement

Exhibit 10.2 Amendment to Restricted Share Unit Agreement This Amendment to Restricted Share Unit Agreement (this “Amendment”) is hereby entered into as of August , 2025 by and between Purple Innovation, Inc. (the “Company”) and (“Participant”), and constitutes an amendment to Participant’s Restricted Share Unit Agreement with the Company dated March [], 2025 (the “RSU Agreement”). Other than expr

Form of Restricted Stock Unit Grant Agreement relating to Special Incentive Bonus Equity Grants

Exhibit 10.3 Purple Innovation, Inc. 2017 EQUITY INCENTIVE PLAN Restricted Share Unit Agreement Purple Innovation, Inc., a Delaware corporation (the “Company“), hereby grants to Participant identified below, as of the below Date of Grant, the right to receive shares of Class A Common Stock, par value $0.0001 per share, in an amount equal to the Number of Shares specified below on the terms and con

Letter Agreement between the Company and John J. Roddy dated March 12, 2025

Exhibit 10.6 March 12, 2025 John J. Roddy Re: Special Recognition Bonus Dear John: Purple Innovation, Inc. (“Company”) is pleased to inform you that if a “Change in Control” (as defined below) occurs prior to August 1, 2025 and you remain employed by the Company until the consummation of the Change in Control, your unpaid Special Recognition Bonus of $355,994 set forth in that certain Special Reco

Second Amendment dated March 12, 2025, to Amended and Restated Employment Agreement of Robert T. DeMartini

Exhibit 10.7 March 12, 2025 Robert D. Martini Re: Special Recognition Bonus Dear Rob: With respect to your unpaid Special Recognition Bonus of $595,000 (“Unpaid Special Recognition Bonus”) set forth in your Amended and Restated Employment Agreement dated March 19, 2022 by and between you and Purple Innovation, Inc. (“Company”) (as amended by the amendment dated January 26, 2024, your “Employment A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SEC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-37523 PURPLE INNOVATION, INC.

Letter Agreement between the Company and Todd E. Vogensen dated March 12, 2025

Exhibit 10.4 March 12, 2025 Todd E. Vogensen Re: Special Recognition Bonus Dear Todd: Purple Innovation, Inc. (“Company”) is pleased to inform you that if a “Change in Control” (as defined below) occurs prior to August 1, 2025 and you remain employed by the Company until the consummation of the Change in Control, your unpaid Special Recognition Bonus of $525,000 set forth in that certain Special R

Second Amendment dated May 2, 2025, to Master Retailer Agreement between the Company and Mattress Firm, Inc.

Exhibit 10.8 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS OF THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. SECOND AMENDMENT TO MASTER RETAILER AGREEMENT This Second Amendment to Master Retailer Agreement (this “Amendment”) is made effective this May 2, 2025 (the “Amendment Effective

Amended and Restated Master Vendor Supply and Services Agreement dated May 2, 2025, between the Company and Tempur Sherwood, LLC.

Exhibit 10.9 CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS OF THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. MASTER VENDOR SUPPLY AND SERVICES AGREEMENT This Master Vendor Supply and Services Agreement and all attachments incorporated by reference (collectively the “Agreement”) by and

Letter Agreement between the Company and Eric S. Haynor dated March 12, 2025

Exhibit 10.5 March 12, 2025 Eric S. Haynor Re: Special Recognition Bonus Dear Eric: Purple Innovation, Inc. (“Company”) is pleased to inform you that if a “Change in Control” (as defined below) occurs prior to August 1, 2025 and you remain employed by the Company until the consummation of the Change in Control, your unpaid Special Recognition Bonus of $436,406 set forth in that certain Special Rec

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 29, 2025 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Emplo

Agreement dated July 24, 2025, between Purple Innovation, Inc. and Todd Vogensen

Exhibit 10.2 July 18, 2025 Todd Vogensen Re: Amendment of Special Recognition Bonus Dear Todd: Purple Innovation, Inc. (“Company”) is pleased to offer you the opportunity, by signing the acceptance below and returning it to me no later than July 24, 2025, to amend in the manner described below sixty-five percent (65%) or $341,250 of your unpaid Special Recognition Bonus of $525,000 set forth in th

Agreement dated July 23, 2025, between Purple Innovation, Inc. and Robert DeMartini

Exhibit 10.1 July 18, 2025 Robert D. Martini Re: Special Recognition Bonus Dear Rob: You and the Company agree sixty-five percent (65%) or $386,750 of your unpaid Special Recognition Bonus of $595,000 set forth in your Amended and Restated Employment Agreement dated March 19, 2022 by and between you and Purple Innovation, Inc. (“Company”) (as amended by the amendments dated January 26, 2024 and Ma

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 23, 2025 Purple Innovation,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 23, 2025 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Emplo

Agreement dated July 24, 2025, between Purple Innovation, Inc. and Eric Haynor

Exhibit 10.3 July 18, 2025 Eric Haynor Re: Amendment of Special Recognition Bonus Dear Eric: Purple Innovation, Inc. (“Company”) is pleased to offer you the opportunity, by signing the acceptance below and returning it to me no later than July 24, 2025, to amend in the manner described below sixty-five percent (65%) or $283,664 of your unpaid Special Recognition Bonus of $436,406 set forth in that

Purple Innovation Reports Second Quarter 2025 Results; Reaffirms 2025 Guidance Net Loss Exceeded Expectations; Adjusted EBITDA Margin Improved 120 Basis Points versus Last Year Strong Rejuvenate 2.0 Demand More than Double the Rejuvenate 1.0 Launch i

Exhibit 99.1 Purple Innovation Reports Second Quarter 2025 Results; Reaffirms 2025 Guidance Net Loss Exceeded Expectations; Adjusted EBITDA Margin Improved 120 Basis Points versus Last Year Strong Rejuvenate 2.0 Demand More than Double the Rejuvenate 1.0 Launch in DTC Mattress Firm Rollout Progressing on Schedule Lehi, Utah, July 29, 2025 – Purple Innovation, Inc. (NASDAQ: PRPL) (“Purple”), a comf

Long-Term Incentive Cash Bonus Agreement dated July 22, 2025, between Purple Innovation, Inc. and Robert DeMartini

Exhibit 10.1 LONG-TERM INCENTIVE CASH BONUS AGREEMENT Purple Innovation, Inc. Long-Term Incentive Cash Bonus Agreement Purple Innovation, Inc., a Delaware corporation (the “Company“), hereby grants to Participant identified below the right to earn a cash bonus payment equal to the Target Amount specified below, as adjusted based on actual performance, subject to the terms and conditions contained

Long-Term Incentive Cash Bonus Agreement dated July 23, 2025, between Purple Innovation, Inc. and Todd Vogensen

Exhibit 10.2 LONG-TERM INCENTIVE CASH BONUS AGREEMENT Purple Innovation, Inc. Long-Term Incentive Cash Bonus Agreement Purple Innovation, Inc., a Delaware corporation (the “Company“), hereby grants to Participant identified below the right to earn a cash bonus payment equal to the Target Amount specified below, as adjusted based on actual performance, subject to the terms and conditions contained

Long-Term Incentive Cash Bonus Agreement dated July 22, 2025, between Purple Innovation, Inc. and Eric Haynor

Exhibit 10.3 LONG-TERM INCENTIVE CASH BONUS AGREEMENT Purple Innovation, Inc. Long-Term Incentive Cash Bonus Agreement Purple Innovation, Inc., a Delaware corporation (the “Company”), hereby grants to Participant identified below the right to earn a cash bonus payment equal to the Target Amount specified below, as adjusted based on actual performance, subject to the terms and conditions contained

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 17, 2025 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Emplo

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 10, 2025 Purple Innovation,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 10, 2025 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Emplo

PURPLE INNOVATION, INC.

PURPLE INNOVATION, INC. May 28, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Purple Innovation, Inc.—Registration Statement on Form S-3 (File No. 333-287560) Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective dat

As filed with the Securities and Exchange Commission on May 23, 2025

As filed with the Securities and Exchange Commission on May 23, 2025 Registration No.

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Purple Innovation, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report PURPLE INNOVATION, INC. (Exact name of the registrant as specified in its charter) Delaware 001-37523 (State or other jurisdiction of incorporation) (Commission file number) 4100 North Chapel Ridge Rd., Suite 200 Lehi, UT 84043 (Address of principal executive offices) (Zip code) Todd Vogen

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2025 Purple Innovation, In

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2025 Purple Innovation, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37523 47-4078206 (State or other jurisdiction of incorporation) (Commission Fil

Registration Rights Agreement, dated as of May 2, 2025, by and between Purple Innovation, Inc. and Somnigroup International, Inc.

Exhibit 10.5 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of May 2, 2025, by and among Purple Innovation, Inc., a Delaware corporation (including any successor entity thereto, “Parent”), and the undersigned parties listed under Investors on the signature page hereto (each an “Investor” and collectively, the “Investors”). WHEREAS, Parent is

Purple Innovation Reports First Quarter 2025 Results; Reaffirms 2025 Guidance Exceeded Q1 Adjusted EBITDA Target; Delivered Q1 Sales Consistent with Guidance GAAP Gross Margin of 39.4% in Q1; Adjusted Gross Margin Above 40% for Fourth Consecutive Qua

Exhibit 99.1 Purple Innovation Reports First Quarter 2025 Results; Reaffirms 2025 Guidance Exceeded Q1 Adjusted EBITDA Target; Delivered Q1 Sales Consistent with Guidance GAAP Gross Margin of 39.4% in Q1; Adjusted Gross Margin Above 40% for Fourth Consecutive Quarter Lehi, Utah, May 6, 2025 – Purple Innovation, Inc. (NASDAQ: PRPL) (“Purple”), a comfort innovation company known for creating the “Wo

Purple Announces Significant Expansion of Commercial Relationship with Somnigroup Agreements meaningfully increase Purple’s footprint in Mattress Firm stores nationwide and provide Purple with strategic supply support from Tempur Sherwood Bolsters Ma

Exhibit 99.1 Purple Announces Significant Expansion of Commercial Relationship with Somnigroup Agreements meaningfully increase Purple’s footprint in Mattress Firm stores nationwide and provide Purple with strategic supply support from Tempur Sherwood Bolsters Mattress Firm’s position as a multi-branded retailer offering customers more choice and value, while enabling Somnigroup to participate in

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2025 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Employe

First Amendment to the Stockholders Right Agreement, dated May 6, 2025, between Purple Innovation, Inc. and Pacific Stock Transfer Company

Exhibit 4.1 FIRST AMENDMENT TO THE STOCKHOLDER RIGHTS AGREEMENT THIS FIRST AMENDMENT TO THE STOCKHOLDER RIGHTS AGREEMENT (this “Amendment”), dated as of May 6, 2025 (the “Effective Date”) is by and between Purple Innovation, Inc., a Delaware corporation (the “Company”), and Pacific Stock Transfer Company, a registered transfer agent, as rights agent (the “Rights Agent”), and amends and terminates

Regulation FD Disclosure, Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 2, 2025 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Employe

Third Amended and Restated Registration Rights Agreement, dated as of May 2, 2025, by and among Purple Innovation, Inc., Coliseum Capital Partners, L.P., Blackwell Partners LLC – Series A, and Coliseum Capital Co-Invest III, L.P.

Exhibit 10.4 THIRD Amended and restated REGISTRATION RIGHTS AGREEMENT THIS THIRD AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of May 2, 2025, by and among Purple Innovation, Inc., a Delaware corporation (including any successor entity thereto, “Parent”), and the undersigned parties listed under Investors on the signature page hereto (each an “Investor” a

Form of Loan Warrant

Exhibit 10.2 Form of Incremental Warrant NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION (THE “COMMISSION”) OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED

Certificate of Elimination of the Preferred Stock of the Company, dated May 6, 2025

Exhibit 3.1 CERTIFICATE OF ELIMINATION OF SERIES C JUNIOR PARTICIPATING PREFERRED STOCK OF PURPLE INNOVATION, INC. Pursuant to Section 151(g) of the General Corporation Law of the State of Delaware Purple Innovation, Inc., a Delaware corporation (the “Company”), does, as of this 6th day of May 2025, hereby certify as follows: 1. Pursuant to Section 151(g) of the General Corporation Law of the Stat

Form of SGI Warrant

Exhibit 10.3 Warrant NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION (THE “COMMISSION”) OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURS

Second Amendment to Amended and Restated Credit Agreement, dated as of May 2, 2025, by and among Purple Innovation, Inc., Purple Innovation, LLC, Intellibed, LLC, Coliseum Capital Partners, L.P., Blackwell Partners LLC - Series A, and CSC Delaware Trust Company

Exhibit 10.1 SECOND AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT This SECOND AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT (this “Amendment”), dated as of May 2, 2025, is entered into among Purple Innovation, LLC, a Delaware limited liability company (the “Company” or “Borrower”), Purple Innovation, Inc., a Delaware corporation (“Holdings”), Intellibed, LLC, a Delaware limited liability

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-37523 PURPLE INNOVATION, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Ru

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement. ☐ Confidential, for Use of the Commission Only (as permitted by Rule

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 4, 2025 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Emplo

List of Subsidiaries of the Registrant.

Exhibit 21.1 Subsidiaries of Purple Innovation, Inc. Subsidiary Name Jurisdiction of Formation Purple Innovation, LLC Delaware Intellibed, LLC Delaware

Form of Warrant.

Exhibit 10.42 Form of Incremental Warrant NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION (THE “COMMISSION”) OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERE

Description of Registered Securities.

Exhibit 4.2 DESCRIPTION OF REGISTERED SECURITIES As of December 31, 2024, Purple Innovation, Inc. (the “company,” “we,” “us” and “our”) had two class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: (i) our Class A Common Stock, par value of $0.0001 per share, and (ii) Series C Junior Participating Preferred Stock Purchase Rights (the “Rights”), both of

Amendment to Amended and Restated Credit Agreement, dated as of March 12, 2025, by and among Purple Innovation, Inc., Purple Innovation, LLC, Intellibed, LLC, Coliseum Capital Partners, L.P., Blackwell Partners LLC – Series A, and CSC Delaware Trust Company.

Exhibit 10.41 FIRST AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT This FIRST AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT (this “Amendment”), dated as of March 12, 2025, is entered into among Purple Innovation, LLC, a Delaware limited liability company (the “Company” or “Borrower”), Purple Innovation, Inc., a Delaware corporation (“Holdings”), Intellibed, LLC, a Delaware limited liabili

Second Amended and Restated Registration Rights Agreement, dated as of March 12, 2025, by and among Purple Innovation, Inc., Coliseum Capital Partners, L.P., Blackwell Partners LLC – Series A and Coliseum Capital Co-Invest III, L.P.

Exhibit 10.43 SECOND Amended and restated REGISTRATION RIGHTS AGREEMENT THIS SECOND AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of March 12, 2025, by and among Purple Innovation, Inc., a Delaware corporation (including any successor entity thereto, “Parent”), and the undersigned parties listed under Investors on the signature page hereto (each an “Inves

Insider Trading Policy.

Exhibit 19.1 Insider Trading Policy Revisions Effective as of October 31, 2023 This policy applies to all officers, directors, employees, and contractors of Purple Innovation, Inc. and its subsidiaries (collectively “Purple”) that are exposed to material nonpublic information of Purple, and supersedes all prior insider trading policies. Under the federal securities laws, it is illegal to trade in

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37523 PURPLE INNOVATION

Purple Innovation Announces Review of Strategic Alternatives to Maximize Shareholder Value Initiates Review Following Receipt of Expressions of Interest Returned to Positive Adjusted EBITDA and Positive Cash Flow Generation in Fourth Quarter 2024 and

Exhibit 99.2 Purple Innovation Announces Review of Strategic Alternatives to Maximize Shareholder Value Initiates Review Following Receipt of Expressions of Interest Returned to Positive Adjusted EBITDA and Positive Cash Flow Generation in Fourth Quarter 2024 and Expanded Credit Facility, Enabling Enhanced Financial Flexibility Lehi, Utah, March 13, 2025 – Purple Innovation, Inc. (NASDAQ: PRPL) (“

Amendment to Amended and Restated Credit Agreement, dated as of March 12, 2025, by and among Purple Innovation, Inc., Purple Innovation, LLC, Intellibed, LLC, Coliseum Capital Partners, L.P., Blackwell Partners LLC - Series A, and CSC Delaware Trust Company

Exhibit 10.1 FIRST AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT This FIRST AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT (this “Amendment”), dated as of March 12, 2025, is entered into among Purple Innovation, LLC, a Delaware limited liability company (the “Company” or “Borrower”), Purple Innovation, Inc., a Delaware corporation (“Holdings”), Intellibed, LLC, a Delaware limited liabilit

Form of Warrant

Exhibit 10.2 Form of Incremental Warrant NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION (THE “COMMISSION”) OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED

Second Amended and Restated Registration Rights Agreement, dated as of March 12, 2025, by and among Purple Innovation, Inc., Coliseum Capital Partners, L.P., Blackwell Partners LLC - Series A and Coliseum Capital Co-Invest III, L.P.

Exhibit 10.3 SECOND Amended and restated REGISTRATION RIGHTS AGREEMENT THIS SECOND AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of March 12, 2025, by and among Purple Innovation, Inc., a Delaware corporation (including any successor entity thereto, “Parent”), and the undersigned parties listed under Investors on the signature page hereto (each an “Invest

Purple Innovation Reports Fourth Quarter and Full Year 2024 Results Returned to Positive Adjusted EBITDA and Cash Flow in Fourth Quarter GAAP Gross Margin of 42.9% in Q4; Adjusted Gross Margin improved Over 810bps in Q4 Versus Last Year Generated Inc

Exhibit 99.1 Purple Innovation Reports Fourth Quarter and Full Year 2024 Results Returned to Positive Adjusted EBITDA and Cash Flow in Fourth Quarter GAAP Gross Margin of 42.9% in Q4; Adjusted Gross Margin improved Over 810bps in Q4 Versus Last Year Generated Incremental Liquidity with New $19.0 Million Term Loan Increase to Support Continued Investments in Innovation and Advertising Lehi, Utah, M

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 13, 2025 Purple Innovation, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37523 47-4078206 (State or other jurisdiction of incorporation) (Commission

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2025 Purple Innovation,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2025 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Empl

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 4, 2025 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Em

Purple Innovation Revises Full Year 2024 Guidance; Company Announces Participation in the 2024 ICR Conference Expects full year net revenue between $486 and $488 million and adjusted EBITDA between $(23) and $(21) million Expects positive cash flow a

Exhibit 99.1 Purple Innovation Revises Full Year 2024 Guidance; Company Announces Participation in the 2024 ICR Conference Expects full year net revenue between $486 and $488 million and adjusted EBITDA between $(23) and $(21) million Expects positive cash flow and adjusted EBITDA in the fourth quarter Lehi, Utah, January 13, 2025 – Purple Innovation, Inc. (NASDAQ: PRPL) (“Purple”), a comfort inno

January 13, 2025 ICR Conference  Disrupting the mattress sector as a category innovator by leveraging proprietary technologies and driving market share gains in the premium mattress category.  Leading premium brand with a passionate consumer follow

Exhibit 99.2 January 13, 2025 ICR Conference  Disrupting the mattress sector as a category innovator by leveraging proprietary technologies and driving market share gains in the premium mattress category.  Leading premium brand with a passionate consumer following and an NPS nearly 2x the largest competitor.  Robust business model – patent - protected, vertically integrated manufacturing with o

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 13, 2025 Purple Innovation, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37523 47-4078206 (State or other jurisdiction of incorporation) (Commissio

Infographic (December 2024).

Exhibit 99.1

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 12, 2024 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS E

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 11, 2024 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS E

Purple Innovation Reports Third Quarter 2024 Results Restructuring Initiatives are On Track and Delivering Significant Margin Improvement GAAP Gross Margin of 29.7%; Adjusted Gross Margin Improved 340bps versus Last Year to 40.5% Adjusted EBITDA Loss

Exhibit 99.1 Purple Innovation Reports Third Quarter 2024 Results Restructuring Initiatives are On Track and Delivering Significant Margin Improvement GAAP Gross Margin of 29.7%; Adjusted Gross Margin Improved 340bps versus Last Year to 40.5% Adjusted EBITDA Loss Narrowed Notably to $(6.4) Million versus $(16.3) Million Last Year Lehi, Utah, November 4, 2024 – Purple Innovation, Inc. (NASDAQ: PRPL

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2024 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Em

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2024 ☐ TRANSITION REPORT PURSUANT T

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-37523 PURPLE INNOVATION, INC.

Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation

Exhibit 4.1 CERTIFICATE OF AMENDMENT TO THE SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF PURPLE INNOVATION, INC. Purple Innovation, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: 1. The original certificate of incorporation was filed with the Secretary of State of the State of Delaware on May 19

Form of Class A Common Stock certificate

Exhibit 4.2 The following abbreviations, when used in the inscription on the face of this certificate, shall be construed as though they were written out in full according to applicable laws or regulations. TEN COM - as tenants in common UNIF GIFT MIN ACT Custodian TEN ENT - as tenants by the entireties (Cust) (Minor) JT TEN - as joint tenants with the right of Act survivorship and not as tenants

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 15, 2024 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State or other jurisdiction of incorporation) (Commissio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement. ☐ Confidential, for Use of the Commission Only (as permitted by Rule

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 1

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 22, 2024 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State or other jurisdiction of incorporation) (Commission

Purple Innovation Announces Consolidation of Manufacturing Operations to Accelerate Growth Actions will expedite Grid innovation and deliver cost synergies Anticipated to generate $15 to $20 million in EBITDA benefit in 2025

Exhibit 99.1 Purple Innovation Announces Consolidation of Manufacturing Operations to Accelerate Growth Actions will expedite Grid innovation and deliver cost synergies Anticipated to generate $15 to $20 million in EBITDA benefit in 2025 LEHI, Utah, Aug. 22, 2024 /PRNewswire/ - Purple Innovation, Inc. (NASDAQ: PRPL) (“Purple”), a comfort innovation company with the #1 Gel Grid technology in the wo

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 1

Purple Innovation Reports Second Quarter 2024 Results

Exhibit 99.1 Purple Innovation Reports Second Quarter 2024 Results Lehi, Utah, August 5, 2024 – Purple Innovation, Inc. (NASDAQ: PRPL) (“Purple”), a comfort innovation company known for creating the “World’s First No Pressure™ Mattress,” today announced results for the second quarter ended June 30, 2024. Second Quarter Financial Summary (Comparisons versus Second Quarter 2023)1 ● Net revenue incre

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SEC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-37523 PURPLE INNOVATION, INC.

Amended Form of Class A Common Stock certificate.

Exhibit 4.3

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2024 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Empl

Certificate of Designation of the Preferred Stock of the Company, dated June 28, 2024

Exhibit 3.1 CERTIFICATE OF DESIGNATION OF SERIES C JUNIOR PARTICIPATING PREFERRED STOCK OF PURPLE INNOVATION, INC. Pursuant to Section 151 of the General Corporation Law of the State of Delaware The undersigned hereby certifies that the following resolution was duly adopted the board of directors of Purple Innovation, Inc., a Delaware corporation (the “Corporation”), on June 27, 2024: RESOLVED, th

Proposed First Amendment to the Second Amended and Restated Certificate of Incorporation

Exhibit 4.2 FIRST AMENDMENT TO THE SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF PURPLE INNOVATION, INC. Purple Innovation, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: 1. The original certificate of incorporation was filed with the Secretary of State of the State of Delaware on May 19, 2015 (t

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 27, 2024 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Emplo

Stockholder Rights Agreement, dated June 27, 2024, between Purple Innovation, Inc. and Pacific Stock Transfer Company

Exhibit 4.1 STOCKHOLDER RIGHTS AGREEMENT Purple Innovation, Inc. and Pacific Stock Transfer Company, as Rights Agent Dated as of June 27, 2024 Table of Contents Page Section 1. Certain Definitions 1 Section 2. Appointment of Rights Agent 9 Section 3. Issuance of Rights Certificates 9 Section 4. Form of Rights Certificates 11 Section 5. Countersignature and Registration 12 Section 6. Transfer, Spli

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 Purple Innovation, Inc. (Exact name of registrant as specified in its charter) Delaware 47-4078206 (State of incorporation or organization) (IRS Employer Identification No.) 4100 North Chapel Ridge

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 12, 2024 Purple Innovation,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 12, 2024 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Emplo

As filed with the Securities and Exchange Commission on May 31, 2024

As filed with the Securities and Exchange Commission on May 31, 2024 Registration No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report PURPLE INNOVATION, INC. (Exact name of the registrant as specified in its charter) Delaware 001-37523 (State or other jurisdiction of incorporation) (Commission file number) 4100 North Chapel Ridge Rd., Suite 200 Lehi, UT 84043 (Address of principal executive offices) (Zip code) Tricia S.

PURPLE INNOVATION, INC.

PURPLE INNOVATION, INC. May 31, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Purple Innovation, Inc.—Registration Statement on Form S-3 (File No. 333-278143) Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective dat

Purple Innovation Reports First Quarter 2024 Results

Exhibit 99.1 Purple Innovation Reports First Quarter 2024 Results Lehi, Utah, May 7, 2024 – Purple Innovation, Inc. (NASDAQ: PRPL), a comfort innovation company known for creating the “World’s First No Pressure ™ Mattress,” today announced results for the first quarter ended March 31, 2024, which were in line with guidance. First Quarter Financial Summary (Comparisons versus First Quarter 2023)1 ●

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2024 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Employe

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-37523 PURPLE INNOVATION, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

DEF 14A 1 ea0203522-01.htm PROXY STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement. ☐ Confidential, for Use of the Commission Only (as permitted by Rule

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Purple Innovation, Inc.

As filed with the Securities and Exchange Commission on March 21, 2024

As filed with the Securities and Exchange Commission on March 21, 2024 Registration No.

Performance Share Unit Agreement between the Company and Tricia McDermott dated March 14, 2023*

Exhibit 99.3 Purple Innovation, Inc. INDUCEMENT GRANT Performance Share Unit Agreement Purple Innovation, Inc., a Delaware corporation (the “Company”), hereby grants to Participant identified below, as of the below Date of Grant, the right to receive shares of Class A common stock, par value $0.0001 per share, in an amount initially equal to the Target Number of Shares specified below on the terms

Offer Letter, dated as of September 21, 2023, between Purple Innovation, LLC and Tricia McDermott, dated September 21, 2023 (incorporated by reference to Exhibit 99.1 to the Company’s Registration Statement on Form S-8 (File No. 001-37523) filed with the SEC on March 14, 2024).

Exhibit 99.1 September 21st, 2023 Dear Tricia, On behalf of Purple Innovation, LLC (“Purple” or the “Company”), it is my pleasure to extend to you this written offer outlining the mutually agreed upon terms of your employment. Key points for your employment and compensation include: Position: Your position will be Chief Legal Officer reporting to Rob DeMartini, Chief Executive Officer. It is antic

Performance Share Unit Agreement between the Company and Todd Vogensen, dated March 14, 2023*

Exhibit 99.4 Purple Innovation, Inc. INDUCEMENT GRANT Performance Share Unit Agreement Purple Innovation, Inc., a Delaware corporation (the “Company”), hereby grants to Participant identified below, as of the below Date of Grant, the right to receive shares of Class A common stock, par value $0.0001 per share, in an amount initially equal to the Target Number of Shares specified below on the terms

Restricted Share Unit Agreement between the Company and Tricia McDermott dated March 14, 2023*

Exhibit 99.5 Purple Innovation, Inc. INDUCEMENT GRANT Restricted Share Unit Agreement Purple Innovation, Inc., a Delaware corporation (the “Company”), hereby grants to Participant identified below, as of the below Date of Grant, the right to receive shares of Class A Common Stock, par value $0.0001 per share, in an amount equal to the Number of Shares specified below on the terms and conditions co

Filing Fee Table*

Exhibit 107 Calculation of Filing Fee Table Form S-8 (Form Type) Purple Innovation, Inc.

Inducement Grants to Executive Officers CFO Todd Vogensen and CLO Tricia McDermott Received Inducement Grants

Exhibit 99.1 Inducement Grants to Executive Officers CFO Todd Vogensen and CLO Tricia McDermott Received Inducement Grants Inducement Equity Grant Lehi, Utah, March 14, 2024 – Purple Innovation, Inc. (NASDAQ: PRPL) (“Purple”), a comfort innovation company known for creating the “World’s First No Pressure® Mattress,” today announced the Todd Vogensen, Chief Financial Officer, and Tricia McDermott,

Restricted Share Unit Agreement between the Company and Todd Vogensen, dated March 14, 2023*

Exhibit 99.6 Purple Innovation, Inc. INDUCEMENT GRANT Restricted Share Unit Agreement Purple Innovation, Inc., a Delaware corporation (the “Company”), hereby grants to Participant identified below, as of the below Date of Grant, the right to receive shares of Class A Common Stock, par value $0.0001 per share, in an amount equal to the Number of Shares specified below on the terms and conditions co

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 14, 2024 PURPLE INNOVATION, INC. (Exact name of registrant as specified in its charter) Delaware 001-37523 47-4078206 (State or other jurisdiction of incorporation) (Commission

As filed with the Securities and Exchange Commission on March 14, 2024

As filed with the Securities and Exchange Commission on March 14, 2024 Registration No.

List of Subsidiaries of the Registrant.

Exhibit 21.1 Subsidiaries of Purple Innovation, Inc. Subsidiary Name Jurisdiction of Formation Purple Innovation, LLC Delaware Intellibed, LLC Delaware

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37523 PURPLE INNOVATION

Purple Innovation Reports Fourth Quarter and Full Year 2023 Results Company Projecting Mid to High Single Digit Percentage Revenue Growth in 2024 with Positive Adjusted EBITDA in the Second Half of the Year

Exhibit 99.1 Purple Innovation Reports Fourth Quarter and Full Year 2023 Results Company Projecting Mid to High Single Digit Percentage Revenue Growth in 2024 with Positive Adjusted EBITDA in the Second Half of the Year Lehi, Utah, March 12, 2024 – Purple Innovation, Inc. (NASDAQ: PRPL) (“Purple”), a comfort innovation company known for creating the “World’s First No Pressure ™ Mattress,” today an

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2024 Purple Innovation,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2024 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Empl

Description of Registered Securities.

Exhibit 4.2 DESCRIPTION OF REGISTERED SECURITIES As of December 31, 2023, Purple Innovation, Inc. (the “company,” “we,” “us” and “our”) had one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: our Class A Common Stock, par value of $0.0001 per share. Description of Class A Common Stock The following description of our registered securities summari

Compensation Clawback Policy

Exhibit 97.1 Purple Innovation, Inc. 2023 INCENTIVE COMPENSATION CLAWBACK POLICY This policy applies to all Officers and Employees of Purple Innovation, Inc. and its subsidiaries who receive incentive compensation. 1. Introduction. The Board of Directors (the “Board”) of Purple Innovation, Inc. (the “Company”), for itself and its subsidiaries, has adopted this policy (the “Policy”) for clawing bac

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 4, 2024 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Emplo

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 2, 2024 Purple Innovatio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 2, 2024 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Em

SEPARATION AGREEMENT AND GENERAL RELEASE

Exhibit 99.1 SEPARATION AGREEMENT AND GENERAL RELEASE This Separation Agreement and General Release (hereinafter “Agreement”) is entered into this February 2, 2024, by and between Casey McGarvey (hereinafter “Employee”), on the one hand, and Purple Innovation, LLC, a Delaware limited liability company (hereinafter “Employer”), on the other hand (collectively, Employee and Employer are referred to

Amendment to the Amended and Restated Employment Agreement dated January 26, 2024, between the Company and Robert T. DeMartini (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (File No. 001-37523) filed on January 26, 2024).

Exhibit 10.1 Amendment to Amended and Restated Employment Agreement This Amendment to Amended and Restated Employment Agreement (this “Amendment”) is hereby entered into as of January 26, 2024 by and between Purple Innovation, Inc. (the “Company”) and Robert T. DeMartini (“you”), and constitutes an amendment to your Amended and Restated Employment Agreement with the Company dated March 19, 2022 (a

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 26, 2024 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State or other jurisdiction of incorporation) (Commissio

Purple Innovation Strengthens Balance Sheet, Creating Greater Financial Flexibility to Execute Growth Strategy Company Reaffirms 2023 Guidance and Provides Update on Efforts to Accelerate Revenue Growth and EBITDA Improvement

Exhibit 99.1 Purple Innovation Strengthens Balance Sheet, Creating Greater Financial Flexibility to Execute Growth Strategy Company Reaffirms 2023 Guidance and Provides Update on Efforts to Accelerate Revenue Growth and EBITDA Improvement LEHI, Utah, January 23, 2024 – Purple Innovation, Inc. (NASDAQ: PRPL) (“Purple” or the “Company”), a comfort innovation company known for creating the “World’s F

Amended and Restated Credit Agreement, dated January 23, 2024, by and among Purple Innovation, Inc., Purple Innovation, LLC, Intellibed, LLC, Coliseum Capital Partners, L.P., Blackwell Partners LLC – Series A, Harvest Small Cap Partners Master, Ltd., Harvest Small Cap Partners, L.P., HSCP Strategic IV, L.P., and Delaware Trust Company (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (File No. 001-37523) filed on January 23, 2024).

Exhibit 10.1 EXECUTION VERSION AMENDED AND RESTATED CREDIT AGREEMENT Dated as of January 23, 2024 among PURPLE INNOVATION, LLC, as a Borrower, PURPLE INNOVATION, INC., as Guarantor, CERTAIN FINANCIAL INSTITUTIONS, as Lenders, and DELAWARE TRUST COMPANY, as Administrative Agent TABLE OF CONTENTS Page ARTICLE I DEFINITIONS AND ACCOUNTING TERMS 1.01 Defined Terms 2 1.02 Other Interpretive Provisions

Amended and Restated Registration Rights Agreement, dated January 23, 2024, by and among Purple Innovation, Inc., Coliseum Capital Partners, L.P., Blackwell Partners LLC – Series A, Coliseum Capital Co-Invest III, L.P., Harvest Small Cap Partners Master, Ltd., Harvest Small Cap Partners, L.P., and HSCP Strategic IV, L.P. (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K (File No. 001-37523) filed on January 23, 2024).

Exhibit 10.3 Amended and restated REGISTRATION RIGHTS AGREEMENT THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of January 23, 2024, by and among Purple Innovation, Inc., a Delaware corporation (including any successor entity thereto, “Parent”), and the undersigned parties listed under Investors on the signature page hereto (each an “Investor” and coll

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 23, 2024 Purple Innovatio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 23, 2024 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Em

Form of Warrant (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K (File No. 001-37523) filed on January 23, 2024).

Exhibit 10.2 Form of Warrant NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION (THE “COMMISSION”) OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXC

PRPL / Purple Innovation, Inc. / Coliseum Capital Management, LLC - SC 13D/A Activist Investment

SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 30)* PURPLE INNOVATION, INC. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 74640Y 106 (CUSIP Number) Christopher Shackelton/Adam Gray 105 Rowayton Avenue Rowayton, CT 06853 with a copy to: Debevoise & Plimpton

Amended and Restated Pledge and Security Agreement, dated January 23, 2024, by and among Purple Innovation, Inc., Purple Innovation, LLC, Intellibed, LLC, and Delaware Trust Company (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K (File No. 001-37523) filed on January 23, 2024).

Exhibit 10.4 AMENDED AND RESTATED PLEDGE AND SECURITY AGREEMENT dated as of January 23, 2024 among PURPLE INNOVATION, LLC, PURPLE INNOVATION, INC. and INTELLIBED, LLC, as Grantors, and DELAWARE TRUST COMPANY, as the Administrative Agent Table of Contents Page Section 1 Definitions 2 Section 2 Grant of Security Interest 6 Section 3 Security for Secured Obligations 7 Section 4 Delivery of the Pledge

Infographic (December 2023).

Exhibit 99.2

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 4, 2023 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Em

Purple Announces Positive Black Friday/Cyber Monday Weekend Selling Period and Reiterates 2023 Full Year Outlook Ahead of Investor Conferences Company Participating in Raymond James TMT & Consumer Conference on December 5 and ROTH MKM Deer Valley Con

Exhibit 99.1 Purple Announces Positive Black Friday/Cyber Monday Weekend Selling Period and Reiterates 2023 Full Year Outlook Ahead of Investor Conferences Company Participating in Raymond James TMT & Consumer Conference on December 5 and ROTH MKM Deer Valley Conference on December 14 Lehi, Utah, December 4, 2023 – Purple Innovation, Inc. (NASDAQ: PRPL) (“Purple”), a comfort innovation company kno

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2023 ☐ TRANSITION REPORT PURSUANT T

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-37523 PURPLE INNOVATION, INC.

First Amendment to Credit Agreement and Limited Waiver, dated November 6, 2023, between and among Purple Innovation, LLC, Purple Innovation, Inc., Intellibed, LLC, the ABL Lenders, the ABL Agent, the Swing Line Lender, and the Letter of Credit Issuer (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (File No. 001-37523) filed on November 9, 2023).

Exhibit 10.1 FIRST AMENDMENT TO CREDIT AGREEMENT AND LIMITED WAIVER This FIRST AMENDMENT TO CREDIT AGREEMENT AND LIMITED WAIVER (this “Amendment”), dated as of November 6, 2023, is entered into among Purple Innovation, LLC, a Delaware limited liability company (the “Company” or “Borrower”), Purple Innovation, Inc., a Delaware corporation (“Holdings”), Intellibed, LLC, a Delaware limited liability

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-SAR ☐ Form N-CSR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-SAR ☐ Form N-CSR For Period Ended: September 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report on Form N-SAR For the Transition Period Ended: Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

Purple Innovation Reports Third Quarter 2023 Results Third Quarter Revenue Increased 19% Sequentially vs. Second Quarter and Just Short of Year Ago New Product Transition Costs Temporarily Weighing on Margins Company Expecting Return to Year-over-Yea

Exhibit 99.1 Purple Innovation Reports Third Quarter 2023 Results Third Quarter Revenue Increased 19% Sequentially vs. Second Quarter and Just Short of Year Ago New Product Transition Costs Temporarily Weighing on Margins Company Expecting Return to Year-over-Year Revenue Growth in the Fourth Quarter Lehi, Utah, November 9, 2023 – Purple Innovation, Inc. (NASDAQ: PRPL) (“Purple”), a comfort innova

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2023 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Em

First Amendment to Term Loan Credit Agreement and Limited Waiver, dated November 6, 2023, between and among Purple Innovation, LLC, Purple Innovation, Inc., Intellibed, LLC,, the Term Loan Agent, and the Term Loan Lenders.

Exhibit 10.2 Execution Version FIRST AMENDMENT TO TERM LOAN CREDIT AGREEMENT AND LIMITED WAIVER This FIRST AMENDMENT TO TERM LOAN CREDIT AGREEMENT AND LIMITED WAIVER (this “Amendment”), dated as of November 6, 2023, is entered into among Purple Innovation, LLC, a Delaware limited liability company (the “Company” or “Borrower”), Purple Innovation, Inc., a Delaware corporation (“Holdings”), Intellib

PURPLE APPOINTS TRICIA MCDERMOTT AS CHIEF LEGAL OFFICER McDermott Brings a Successful Track Record of Leading Legal Departments and Driving Intellectual Property Transactions at Several Multibillion Dollar Retail Brands

Exhibit 99.1 PURPLE APPOINTS TRICIA MCDERMOTT AS CHIEF LEGAL OFFICER McDermott Brings a Successful Track Record of Leading Legal Departments and Driving Intellectual Property Transactions at Several Multibillion Dollar Retail Brands Lehi, Utah, September 27, 2023 – Purple Innovation, Inc. (NASDAQ: PRPL) (“Purple”), the world leader in sleep innovation and inventor of GelFlex® Grid Technology, toda

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 21, 2023 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 19, 2023 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State or other jurisdiction of incorporation) (Commiss

Offer Letter Entered into between Purple Innovation, LLC and Todd E. Vogensen dated September 19, 2023 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K (File No. 001-37523) filed on September 21, 2023).

Exhibit 10.1 September 18th, 2023 Dear Todd, On behalf of Purple Innovation, LLC (“Purple” or the “Company”), it is my pleasure to extend to you this written offer outlining the mutually agreed upon terms of your employment. Key points for your employment and compensation include: Position: Your position will be Chief Financial Officer reporting to Rob DeMartini, Chief Executive Officer. It is ant

PURPLE APPOINTS TODD VOGENSEN AS CHIEF FINANCIAL OFFICER Vogensen Brings a Successful Track Record Driving Results at Multi-Billion Dollar Retailers

Exhibit 99.1 PURPLE APPOINTS TODD VOGENSEN AS CHIEF FINANCIAL OFFICER Vogensen Brings a Successful Track Record Driving Results at Multi-Billion Dollar Retailers Lehi, Utah, September 21, 2023 – Purple Innovation, Inc. (NASDAQ: PRPL) (“Purple”), the world leader in sleep innovation and inventor of GelFlex® Grid Technology, today announced the appointment of Todd Vogensen as its Chief Financial off

Purple Innovation Reports Second Quarter 2023 Results Largest Product Introduction Points Business in the Right Direction

Exhibit 99.1 Purple Innovation Reports Second Quarter 2023 Results Largest Product Introduction Points Business in the Right Direction Lehi, Utah, August 9, 2023 – Purple Innovation, Inc. (NASDAQ: PRPL) (“Purple”), a comfort innovation company known for creating the “World’s First No Pressure™ Mattress,” today announced results for the second quarter ended June 30, 2023. Second Quarter Financial S

ABL Pledge and Security Agreement dated as of August 7, 2023 (incorporated by reference to Exhibit 10.11 to the Company’s Quarterly Report on Form 10-Q (File No. 001-37523) filed on August 9, 2023).

Exhibit 10.11 PLEDGE AND SECURITY AGREEMENT dated as of August 7, 2023 among PURPLE INNOVATION, LLC, PURPLE INNOVATION, INC. and INTELLIBED, LLC, as Grantors, and BANK OF MONTREAL, as the Administrative Agent Table of Contents Page Section 1 Definitions 2 Section 2 Grant of Security Interest 6 Section 3 Security for Secured Obligations 7 Section 4 Delivery of the Pledged Interests 8 Section 5 Repr

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2023 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Empl

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SEC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-37523 PURPLE INNOVATION, INC.

Term Loan Credit Agreement dated as of August 7, 2023 between and among Purple Innovation, LLC, Purple Innovation, Inc., Intellibed, LLC, the Term Loan Agent and the Term Loan Lenders (incorporated by reference to Exhibit 10.8 to the Company’s Quarterly Report on Form 10-Q (File No. 001-37523) filed on August 9, 2023).

Exhibit 10.8 TERM LOAN CREDIT AGREEMENT Dated as of August 7, 2023 among PURPLE INNOVATION, LLC, as a Borrower, PURPLE INNOVATION, INC., as Guarantor, CERTAIN FINANCIAL INSTITUTIONS, as Lenders, and CALLODINE COMMERCIAL FINANCE, LLC, as Administrative Agent Table of Contents Page ARTICLE I DEFINITIONS AND ACCOUNTING TERMS 1.01 Defined Terms 1 1.02 Other Interpretive Provisions 46 1.03 Accounting T

Term Loan Pledge and Security Agreement dated as of August 7, 2023

Exhibit 10.9 PLEDGE AND SECURITY AGREEMENT dated as of August 7, 2023 among PURPLE INNOVATION, LLC, PURPLE INNOVATION, INC. and INTELLIBED, LLC, as Grantors, and CALLODINE COMMERCIAL FINANCE, LLC, as the Administrative Agent Page Section 1 Definitions. 2 Section 2 Grant of Security Interest 6 Section 3 Security for Secured Obligations 8 Section 4 Delivery of the Pledged Interests. 8 Section 5 Repr

ABL Credit Agreement dated as of August 7, 2023 between and among Purple Innovation, LLC, Purple Innovation, Inc., Intellibed, LLC, the ABL Agent, the Swing Line Lender, the Letter of Credit Issuer and the ABL Lenders (incorporated by reference to Exhibit 10.10 to the Company’s Quarterly Report on Form 10-Q (File No. 001-37523) filed on August 9, 2023).

Exhibit 10.10 CREDIT AGREEMENT Dated as of August 7, 2023 among PURPLE INNOVATION, LLC, as a Borrower, PURPLE INNOVATION, INC., as Guarantor, CERTAIN FINANCIAL INSTITUTIONS, as Lenders, and BANK OF MONTREAL, as Administrative Agent and Swing Line Lender BMO Capital Markets, as Arranger and Book Runner Table of Contents Page ARTICLE I DEFINITIONS AND ACCOUNTING TERMS 1.01 Defined Terms 1 1.02 Other

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 16, 2023 Purple Innovation,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 16, 2023 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Emplo

Purple Innovation, Inc. Amended and Restated 2017 Equity Incentive Plan (incorporated by reference to Exhibit 99.1 to the S-8 (File No. 333-272712) filed with the SEC on June 16, 2023).

Exhibit 99.1 PURPLE INNOVATION, INC. AMENDED AND RESTATED 2017 EQUITY INCENTIVE PLAN 1. Purpose. The purpose of the Purple Innovation, Inc. Amended and Restated 2017 Equity Incentive Plan is to provide a means through which the Company and its Affiliates may attract and retain key personnel and to provide a means whereby directors, officers, managers, employees, consultants and advisors of the Com

As filed with the Securities and Exchange Commission on June 16, 2023

As filed with the Securities and Exchange Commission on June 16, 2023 Registration No.

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Purple Innovation, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 1

Purple Innovation Reports First Quarter 2023 Results

Exhibit 99.1 Purple Innovation Reports First Quarter 2023 Results Lehi, Utah, May 10, 2023 – Purple Innovation, Inc. (NASDAQ: PRPL) (“Purple”), a comfort innovation company known for creating the “World’s First No Pressure ™ Mattress,” today announced results for the first quarter ended March 31, 2023. First Quarter Financial Summary (Comparisons versus First Quarter 2022)1 ● Net revenue decreased

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-37523 PURPLE INNOVATION, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2023 Purple Innovation, I

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 10, 2023 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Employ

Sixth Amendment to the 2020 Credit Agreement dated May 10, 2023 by and among Purple Innovation, LLC, Purple Innovation, Inc., Intellibed, LLC and KeyBank National Association (incorporated by reference to Exhibit 10.13 to the Company’s Quarterly Report on Form 10-Q (File No. 001-37523) filed on May 10, 2023).

Exhibit 10.13 Execution Version SIXTH AMENDMENT TO CREDIT AGREEMENT This SIXTH AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of May 10, 2023, among purple innovation, inc., a Delaware corporation (“Holdings”), purple innovation, llc, a Delaware limited liability company (the “Borrower”), and KEYBANK NATIONAL ASSOCIATION, as administrative agent (in such capacity, the “Administrative A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37523

Certificate of Elimination of the Series A Junior Participating Preferred Stock, dated April 27, 2023 (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed April 27, 2023).

Exhibit 3.1 CERTIFICATE OF ELIMINATION OF SERIES A JUNIOR PARTICIPATING PREFERRED STOCK OF PURPLE INNOVATION, INC. Pursuant to Section 151(g) of the General Corporation Law of the State of Delaware Purple Innovation, Inc., a Delaware corporation (the “Company”), does, as of this 27th day of April 2023, hereby certify as follows: 1. Pursuant to Section 151(g) of the General Corporation Law of the S

Certificate of Elimination of the Proportional Representation Preferred Linked Stock, dated April 27, 2023 (incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K filed April 27, 2023).

Exhibit 3.2 CERTIFICATE OF ELIMINATION OF PROPORTIONAL REPRESENTATION PREFERRED LINKED STOCK OF PURPLE INNOVATION, INC. Pursuant to Section 151(g) of the General Corporation Law of the State of Delaware Purple Innovation, Inc., a Delaware corporation (the “Company”), does, as of this 27th day of April 2023, hereby certify as follows: 1. Pursuant to Section 151(g) of the General Corporation Law of

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2023 Purple Innovation,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2023 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Empl

First Amendment to Stockholder Rights Agreement, dated April 27, 2023, by and between Purple Innovation, Inc. and Pacific Stock Transfer Company

Exhibit 4.1 FIRST AMENDMENT TO STOCKHOLDER RIGHTS AGREEMENT THIS FIRST AMENDMENT TO THE STOCKHOLDER RIGHTS AGREEMENT, dated as of April 27, 2023 (this “Amendment”), is made by and between Purple Innovation, Inc., a Delaware corporation (the “Company”), and Pacific Stock Transfer Company, a registered transfer agent, as rights agent (the “Rights Agent”). WHEREAS, the Company and the Rights Agent en

Cooperation Agreement between Purple Innovation, Inc. and Coliseum Capital Management, LLC, dated April 19, 2023 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed April 21, 2023).

Exhibit 10.1 COOPERATION AGREEMENT This Cooperation Agreement (this “Agreement”), dated as of April 19, 2023, is by and between Coliseum Capital Management, LLC, a Delaware limited liability company (“Coliseum”) and Purple Innovation, Inc., a Delaware corporation (the “Company”), and, solely for purposes of Section 2(f) and the releases set forth in Section 2(g) of this Agreement, Pano Anthos, Gar

PRPL / Purple Innovation Inc - Class A / Coliseum Capital Management, LLC - SC 13D/A Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 29)* PURPLE INNOVATION, INC. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 74640Y 106 (CUSIP Number) Christopher Shackelton/Adam Gray 105 Rowayton Avenue Rowayton, CT 06853 with a copy to: Debevoise & Plimpton LLP Atte

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 19, 2023 Purple Innovation,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 19, 2023 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Empl

COOPERATION AGREEMENT

EX-99.1 Exhibit 99.1 Execution Version COOPERATION AGREEMENT This Cooperation Agreement (this “Agreement”), dated as of April 19, 2023, is by and between Coliseum Capital Management, LLC, a Delaware limited liability company (“Coliseum”) and Purple Innovation, Inc., a Delaware corporation (the “Company”), and, solely for purposes of Section 2(f) and the releases set forth in Section 2(g) of this A

Third Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed April 21, 2023).

Exhibit 3.1 THIRD AMENDED AND RESTATED BYLAWS OF PURPLE INNOVATION, INC. A DELAWARE CORPORATION (THE “CORPORATION”) (FORMERLY KNOWN AS GLOBAL PARTNER ACQUISITION CORP.) ARTICLE I OFFICES Section 1.1. Registered Office. The registered office of the Corporation within the State of Delaware shall be located at either (a) the principal place of business of the Corporation in the State of Delaware or (

Cooperation Agreement dated April 19, 2023

Exhibit 10.1 COOPERATION AGREEMENT This Cooperation Agreement (this “Agreement”), dated as of April 19, 2023, is by and between Coliseum Capital Management, LLC, a Delaware limited liability company (“Coliseum”) and Purple Innovation, Inc., a Delaware corporation (the “Company”), and, solely for purposes of Section 2(f) and the releases set forth in Section 2(g) of this Agreement, Pano Anthos, Gar

Third Amended and Restated Bylaws

Exhibit 3.1 THIRD AMENDED AND RESTATED BYLAWS OF PURPLE INNOVATION, INC. A DELAWARE CORPORATION (THE “CORPORATION”) (FORMERLY KNOWN AS GLOBAL PARTNER ACQUISITION CORP.) ARTICLE I OFFICES Section 1.1. Registered Office. The registered office of the Corporation within the State of Delaware shall be located at either (a) the principal place of business of the Corporation in the State of Delaware or (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 19, 2023 Purple Innovation,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 19, 2023 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Empl

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 13, 2023 Purple Innovation,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 13, 2023 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Empl

Purple Innovation, Inc. 2023 Short-Term Cash Incentive Plan, dated as of April 13, 2023

Exhibit 99.1 PURPLE INNOVATION, INC. 2023 SHORT-TERM CASH INCENTIVE PLAN The Board of Directors (the “Board”) of Purple Innovation, Inc., for itself and its subsidiaries (collectively “Company”), has adopted this Purple Innovation, Inc. 2023 Short-Term Cash Incentive Plan (the “Plan”) as of April 13. 2023. 1. Purpose of Plan. The purposes of the Plan are to provide clear focus on the Company’s ann

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 13, 2023 Purple Innovation,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 13, 2023 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Empl

Form of Restricted Share Unit Agreement

Exhibit 99.2 Purple Innovation, Inc. 2017 EQUITY INCENTIVE PLAN Restricted Share Unit Agreement Purple Innovation, Inc., a Delaware corporation (the “Company“), hereby grants to Participant identified below, as of the below Date of Grant, the right to receive shares of Class A Common Stock, par value $0.0001 per share, in an amount equal to the Number of Shares specified below on the terms and con

Form of Performance-Based Share Unit Agreement

Exhibit 99.3 Purple Innovation, Inc. 2017 EQUITY INCENTIVE PLAN Performance-Based Share Unit Agreement Purple Innovation, Inc., a Delaware corporation (the “Company“), hereby grants to Participant identified below, as of the below Date of Grant, the right to receive shares of Class A common stock, par value $0.0001 per share, in an amount initially equal to the Target Number of Shares specified be

Purple Innovation, Inc. 2017 EQUITY INCENTIVE PLAN Performance-Based Share Unit Agreement

Exhibit 99.3 Purple Innovation, Inc. 2017 EQUITY INCENTIVE PLAN Performance-Based Share Unit Agreement Purple Innovation, Inc., a Delaware corporation (the “Company“), hereby grants to Participant identified below, as of the below Date of Grant, the right to receive shares of Class A common stock, par value $0.0001 per share, in an amount initially equal to the Target Number of Shares specified be

PURPLE INNOVATION, INC. 2023 SHORT-TERM CASH INCENTIVE PLAN

Exhibit 99.1 PURPLE INNOVATION, INC. 2023 SHORT-TERM CASH INCENTIVE PLAN The Board of Directors (the “Board”) of Purple Innovation, Inc., for itself and its subsidiaries (collectively “Company”), has adopted this Purple Innovation, Inc. 2023 Short-Term Cash Incentive Plan (the “Plan”) as of April 13. 2023. 1. Purpose of Plan. The purposes of the Plan are to provide clear focus on the Company’s ann

Purple Innovation, Inc. 2017 EQUITY INCENTIVE PLAN Restricted Share Unit Agreement

Exhibit 99.2 Purple Innovation, Inc. 2017 EQUITY INCENTIVE PLAN Restricted Share Unit Agreement Purple Innovation, Inc., a Delaware corporation (the “Company“), hereby grants to Participant identified below, as of the below Date of Grant, the right to receive shares of Class A Common Stock, par value $0.0001 per share, in an amount equal to the Number of Shares specified below on the terms and con

MEMORANDUM OF UNDERSTANDING

Exhibit 99.1 EXECUTION VERSION MEMORANDUM OF UNDERSTANDING This Memorandum of Understanding (“MOU”) is entered into this 11th day of April 2023, by and among the undersigned parties and sets forth the material terms and conditions under which the parties have agreed to settle the action entitled Coliseum Capital Management, LLC v. Paul Zepf et al., C.A. No. 2023-0220-PAF (the “Action”). 1. The par

MEMORANDUM OF UNDERSTANDING

EX-99.1 Exhibit 99.1 EXECUTION VERSION MEMORANDUM OF UNDERSTANDING This Memorandum of Understanding (“MOU”) is entered into this 11th day of April 2023, by and among the undersigned parties and sets forth the material terms and conditions under which the parties have agreed to settle the action entitled Coliseum Capital Management, LLC v. Paul Zepf et al., C.A. No. 2023-0220-PAF (the “Action”). 1.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 11, 2023 Purple Innovation,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 11, 2023 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Empl

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 11, 2023 Purple Innovation,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 11, 2023 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Empl

Press Release issued by the Company on April 13, 2023

Exhibit 99.2 Purple Innovation Announces Cooperative Framework with Coliseum Capital Company to Welcome New Directors to Board Adam Gray to Serve as Board Chair Gary DiCamillo to Continue to Serve as Lead Independent Director Company Will Redeem Cumulative Voting Proportional Representation Preferred Linked Stock LEHI, Utah – April 13, 2023 – Purple Innovation, Inc. (NASDAQ: PRPL) (“Purple” or the

Memorandum of Understanding dated April 11, 2013

Exhibit 99.1 EXECUTION VERSION MEMORANDUM OF UNDERSTANDING This Memorandum of Understanding (“MOU”) is entered into this 11th day of April 2023, by and among the undersigned parties and sets forth the material terms and conditions under which the parties have agreed to settle the action entitled Coliseum Capital Management, LLC v. Paul Zepf et al., C.A. No. 2023-0220-PAF (the “Action”). 1. The par

PRPL / Purple Innovation Inc - Class A / Coliseum Capital Management, LLC - SC 13D/A Activist Investment

SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 28)* PURPLE INNOVATION, INC. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 74640Y 106 (CUSIP Number) Christopher Shackelton/Adam Gray 105 Rowayton Avenue Rowayton, CT 06853 with a copy to: Debevoise & Plimpton

Purple Innovation Announces Cooperative Framework with Coliseum Capital Company to Welcome New Directors to Board Adam Gray to Serve as Board Chair Gary DiCamillo to Continue to Serve as Lead Independent Director Company Will Redeem Cumulative Voting

Exhibit 99.2 Purple Innovation Announces Cooperative Framework with Coliseum Capital Company to Welcome New Directors to Board Adam Gray to Serve as Board Chair Gary DiCamillo to Continue to Serve as Lead Independent Director Company Will Redeem Cumulative Voting Proportional Representation Preferred Linked Stock LEHI, Utah – April 13, 2023 – Purple Innovation, Inc. (NASDAQ: PRPL) (“Purple” or the

List of Subsidiaries of the Registrant.

Exhibit 21.1 Subsidiaries of Purple Innovation, Inc. Subsidiary Name Jurisdiction of Formation Purple Innovation, LLC Delaware Intellibed, LLC Delaware

Exhibit 4.3

Exhibit 4.3 DESCRIPTION OF REGISTERED SECURITIES The following description of registered securities of Purple Innovation, Inc. (the “company,” “we,” “us” and “our”) summarizes certain provisions of our Second Amended and Restated Certificate of incorporation and our Amended and Restated Bylaws. The description is intended as a summary, and is qualified in its entirety by reference to our Second Am

Power of Attorney (included on signature page) (incorporated by reference to Exhibit 24.1 to the Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed on March 22, 2023).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-37523 PURPLE INNOVATION

Amended and Restated Option Grant Agreement (Reissued) dated March 15, 2023, between the Company and Robert T. DeMartini.

Exhibit 10.4 Purple Innovation, Inc. 2017 EQUITY INCENTIVE PLAN Amended and Restated Option Grant Agreement (Reissued) This Amended and Restated Option Grant Agreement evidences the grant of a Nonqualified Stock Option (the “Grant”) to the individual whose name appears below (the “Participant”), covering the specific number of shares of stock set forth below, on the terms and conditions contained

Amended and Restated Restricted Share Unit Agreement (Reissued Excess Subject to Approval) dated March 15, 2023, between the Company and Robert T. DeMartini (incorporated by reference to Exhibit 10.5 to the Company’s Current Report on Form 8-K filed on March 21, 2023).

Exhibit 10.5 Purple Innovation, Inc. 2017 EQUITY INCENTIVE PLAN Amended and Restated Restricted Share Unit Agreement (Reissued Excess Subject to Approval) Subject to shareholder approval of proposed amendments to Section 5(f) of the Company’s 2017 Equity Incentive Plan (the “Plan”), Purple Innovation, Inc., a Delaware corporation (the “Company”), hereby grants to Participant identified below, as o

Amended and Restated Option Grant Agreement dated March 15, 2023, between the Company and Robert T. DeMartini (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed March 21, 2023).

Exhibit 10.2 Purple Innovation, Inc. 2017 EQUITY INCENTIVE PLAN Amended and Restated Option Grant Agreement This Amended and Restated Option Grant Agreement evidences the grant of a Nonqualified Stock Option (the “Grant”), pursuant to the provisions of the Purple Innovation, Inc. 2017 Equity Incentive Plan (the “Plan”) to the individual whose name appears below (the “Participant”), covering the sp

Amended and Restated Restricted Share Unit Agreement dated March 15, 2023, between the Company and Robert T. DeMartini (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed March 21, 2023).

Exhibit 10.1 Purple Innovation, Inc. 2017 EQUITY INCENTIVE PLAN Amended and Restated Restricted Share Unit Agreement Purple Innovation, Inc., a Delaware corporation (the “Company”), hereby grants to Participant identified below, as of the below Date of Grant, the right to receive shares of Class A Common Stock, par value $0.0001 per share, in an amount equal to the Number of Shares specified below

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 15, 2023 Purple Innovation,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 15, 2023 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Empl

Amended and Restated Option Grant Agreement (Reissued Excess Subject to Approval) dated March 15, 2023, between the Company and Robert T. DeMartini (incorporated by reference to exhibit 10.6 to the Company’s Current Report on Form 8-K filed on March 21, 2023).

EX-10.6 7 ea175595ex10-6purple.htm AMENDED AND RESTATED OPTION GRANT AGREEMENT (REISSUED EXCESS SUBJECT TO APPROVAL) DATED MARCH 15, 2023, BETWEEN THE COMPANY AND ROBERT T. DEMARTINI Exhibit 10.6 Purple Innovation, Inc. 2017 EQUITY INCENTIVE PLAN Amended and Restated Option Grant Agreement (Reissued Excess Subject to Approval) Subject to shareholder approval of proposed amendments to Section 5(f)

Amended and Restated Restricted Share Unit Agreement (Reissued) dated March 15, 2023, between the Company and Robert T. DeMartini (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed March 21, 2023).

Exhibit 10.3 Purple Innovation, Inc. 2017 EQUITY INCENTIVE PLAN Amended and Restated Restricted Share Unit Agreement (Reissued) Purple Innovation, Inc., a Delaware corporation (the “Company“), hereby grants to Participant identified below, as of the below Date of Grant, the right to receive shares of Class A Common Stock, par value $0.0001 per share, in an amount equal to the Number of Shares spec

Purple Innovation Reports Fourth Quarter and Full Year 2022 Results

Exhibit 99.1 Purple Innovation Reports Fourth Quarter and Full Year 2022 Results Lehi, Utah, March 16, 2023 – Purple Innovation, Inc. (NASDAQ: PRPL) (“Purple”), a comfort innovation company known for creating the “World’s First No Pressure ™ Mattress,” today announced results for the fourth quarter and year ended December 31, 2022. Fourth Quarter Financial Summary (Comparisons versus Fourth Quarte

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, 2022 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q For the Transition Period Ended: Read Instruction (on back page) Before Preparing Form.

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 16, 2023 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Empl

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Defin

Fifth Amendment to the 2020 Credit Agreement dated February 17, 2023 by and among Purple Innovation, LLC, Purple Innovation, Inc., KeyBank National Association, and the other lenders party thereto (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K (File No. 001-37523) filed with the SEC on February 21, 2023).

Exhibit 10.1 EXECUTION VERSION FIFTH AMENDMENT TO CREDIT AGREEMENT FIFTH AMENDMENT TO CREDIT AGREEMENT (this “Fifth Amendment”), dated as of February 17, 2023, among purple innovation, inc., a Delaware corporation (“Holdings”), purple innovation, llc, a Delaware limited liability company (the “Borrower”), the LENDERS (as defined below) party hereto (the “Fifth Amendment Lenders”) and KEYBANK NATIO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 17, 2023 PURPLE INNOVATI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 17, 2023 PURPLE INNOVATION, INC. (Exact name of registrant as specified in its charter) Delaware 001-37523 47-4078206 (State or other jurisdiction of incorporation) (Commissi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

DFAN14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

Coliseum Capital Files Lawsuit Against Purple Innovation Non-Executive Directors to Ensure Fair and Democratic Board Election Asserts Purple’s Recently Issued Preferred Stock Violates Company’s Charter and Directors’ Fiduciary Duties; Must be Declare

EX-99.1 Exhibit 99.1 Coliseum Capital Files Lawsuit Against Purple Innovation Non-Executive Directors to Ensure Fair and Democratic Board Election Asserts Purple’s Recently Issued Preferred Stock Violates Company’s Charter and Directors’ Fiduciary Duties; Must be Declared Invalid and Unenforceable Believes Actions Taken by Purple Special Committee are Desperate Attempt to Disenfranchise Stockholde

PRPL / Purple Innovation Inc - Class A / Coliseum Capital Management, LLC - SC 13D/A Activist Investment

SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 27)* PURPLE INNOVATION, INC. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 74640Y 106 (CUSIP Number) Christopher Shackelton/Adam Gray 105 Rowayton Avenue Rowayton, CT 06853 with a copy to: Debevoise & Plimpton

PRPL / Purple Innovation Inc / Coliseum Capital Management, LLC - SC 13D/A Activist Investment

SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 26)* PURPLE INNOVATION, INC. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 74640Y 106 (CUSIP Number) Christopher Shackelton/Adam Gray 105 Rowayton Avenue Rowayton, CT 06853 with a copy to: Debevoise & Plimpton

Certificate of Designation of Proportional Representation Preferred Linked Stock of the Company, dated February 14, 2023 (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K (File No. 001-37523) filed with the SEC on February 14, 2023).

Exhibit 3.1 CERTIFICATE OF DESIGNATION OF PROPORTIONAL REPRESENTATION PREFERRED LINKED STOCK OF PURPLE INNOVATION, INC. Pursuant to Section 151 of the General Corporation Law of the State of Delaware The undersigned hereby certifies that the following resolution was duly adopted by a special committee of the board of directors of Purple Innovation, Inc., a Delaware corporation (the “Corporation”),

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2023 PURPLE INNOVATI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2023 PURPLE INNOVATION, INC. (Exact name of registrant as specified in its charter) Delaware 001-37523 47-4078206 (State or other jurisdiction of incorporation) (Commissi

Press Release issued by the Company on February 14, 2023

Exhibit 99.1 Purple Special Committee Takes Action to Protect Rights of All Shareholders in Face of Coliseum Capital Management’s Effort to Gain Control of the Company Issues Cumulative Voting Preferred Stock to Provide Purple Shareholders with the Ability to Obtain Proportional Representation on Company’s Board of Directors LEHI, Utah, Feb. 14, 2023 - Purple Innovation, Inc. (NASDAQ: PRPL) ("Purp

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 PURPLE INNOVATION, INC. (Exact name of regist

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 PURPLE INNOVATION, INC. (Exact name of registrant as specified in its charter) Delaware 47-4078206 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission only (as permitted by Rule 14a-6(e)(2)) ☐ Defin

Purple Special Committee Takes Action to Protect Rights of All Shareholders in Face of Coliseum Capital Management’s Effort to Gain Control of the Company Issues Cumulative Voting Preferred Stock to Provide Purple Shareholders with the Ability to Obt

EX-99.1 3 ea173509ex99-1purpleinn.htm PRESS RELEASE ISSUED BY THE COMPANY ON FEBRUARY 14, 2023 Exhibit 99.1 Purple Special Committee Takes Action to Protect Rights of All Shareholders in Face of Coliseum Capital Management’s Effort to Gain Control of the Company Issues Cumulative Voting Preferred Stock to Provide Purple Shareholders with the Ability to Obtain Proportional Representation on Company

Certificate of Designation of Proportional Representation Preferred Linked Stock of the Company, dated February 14, 2023

Exhibit 3.1 CERTIFICATE OF DESIGNATION OF PROPORTIONAL REPRESENTATION PREFERRED LINKED STOCK OF PURPLE INNOVATION, INC. Pursuant to Section 151 of the General Corporation Law of the State of Delaware The undersigned hereby certifies that the following resolution was duly adopted by a special committee of the board of directors of Purple Innovation, Inc., a Delaware corporation (the “Corporation”),

Certificate of Designation of Proportional Representation Preferred Linked Stock of the Company, dated February 14, 2023

Exhibit 3.1 CERTIFICATE OF DESIGNATION OF PROPORTIONAL REPRESENTATION PREFERRED LINKED STOCK OF PURPLE INNOVATION, INC. Pursuant to Section 151 of the General Corporation Law of the State of Delaware The undersigned hereby certifies that the following resolution was duly adopted by a special committee of the board of directors of Purple Innovation, Inc., a Delaware corporation (the “Corporation”),

Regulation FD Disclosure, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2023 PURPLE INNOVATION, INC. (Exact name of registrant as specified in its charter) Delaware 001-37523 47-4078206 (State or other jurisdiction of incorporation) (Commissi

PRPL / Purple Innovation Inc / Coliseum Capital Management, LLC - SC 13D/A Activist Investment

SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 25)* PURPLE INNOVATION, INC. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 74640Y 106 (CUSIP Number) Christopher Shackelton/Adam Gray 105 Rowayton Avenue Rowayton, CT 06853 with a copy to: Debevoise & Plimpton

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2023 Purple Innovati

DEFA14A 1 d429624ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2023 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State or other ju

LOCK-UP AGREEMENT Purple Innovation, Inc. Lock-up Agreement

EX-99.2 3 d420155dex992.htm EX-99.2 Exhibit 99.2 LOCK-UP AGREEMENT Purple Innovation, Inc. Lock-up Agreement February 7, 2023 BMO Capital Markets Corp. KeyBanc Capital Markets Inc. As Representatives of the Several Underwriters c/o BMO Capital Markets Corp. 151 W 42nd Street New York, New York 10036 and c/o KeyBanc Capital Markets Inc. 127 Public Square Cleveland, Ohio 44114 Re: Proposed Public Of

COLISEUM NOMINATES SLATE OF HIGHLY QUALIFIED AND ENGAGED DIRECTOR CANDIDATES FOR ELECTION AT PURPLE INNOVATION 2023 ANNUAL MEETING Will Support Re-Election of CEO Rob DeMartini to Board No Longer Pursuing September 2022 Take Private Proposal Sharehol

EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE COLISEUM NOMINATES SLATE OF HIGHLY QUALIFIED AND ENGAGED DIRECTOR CANDIDATES FOR ELECTION AT PURPLE INNOVATION 2023 ANNUAL MEETING Will Support Re-Election of CEO Rob DeMartini to Board No Longer Pursuing September 2022 Take Private Proposal Shareholders Deserve Nimbler, More Engaged Board with Heightened Sense of Urgency and Bias for Action to Help Manag

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2023 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State or other jurisdiction of incorporation) (Commissi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. )

DFAN14A 1 d459412ddfan14a.htm DFAN14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☐ Filed by a Party other than the Registrant ☒ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, For Use of t

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 8, 2023 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Em

Underwriting Agreement, dated February 8, 2023, by and between Purple Innovation, Inc., BMO Capital Markets Corp. and KeyBanc Capital Markets Inc.

Exhibit 1.1 13,400,000 Shares PURPLE INNOVATION, INC. Class A Common Stock UNDERWRITING AGREEMENT February 8, 2023 BMO Capital Markets Corp. KeyBanc Capital Markets Inc. As Representatives of the Several Underwriters c/o BMO Capital Markets Corp. 151 W 42nd Street New York, New York 10036 and c/o KeyBanc Capital Markets Inc. 127 Public Square Cleveland, Ohio 44114 Ladies and Gentlemen: Purple Inno

Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 8, 2023 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State or other jurisdiction of incorporation) (Commissio

13,400,000 Shares Purple Innovation, Inc. Class A common stock $4.50 Per Share

Table of Contents As filed pursuant to Rule 424(b)(5) Registration No. 333-269005 Prospectus Supplement (to Prospectus dated January 30, 2023) 13,400,000 Shares Purple Innovation, Inc. Class A common stock $4.50 Per Share We are offering 13,400,000 shares of our Class A common stock. Our Class A common stock trades on the Nasdaq Global Select Market under the trading symbol “PRPL.” On February 8,

Purple Innovation, Inc. Announces Pricing of Upsized Public Offering of Class A Common Stock

EX-99.1 4 d458708dex991.htm EX-99.1 Exhibit 99.1 Purple Innovation, Inc. Announces Pricing of Upsized Public Offering of Class A Common Stock Lehi, Utah, February 8, 2023 – Purple Innovation, Inc. (NASDAQ: PRPL) (“Purple” or the “Company”), a comfort innovation company known for creating the “World’s First No Pressure® Mattress,” today announced the pricing of an underwritten public offering by th

$50,000,000 Purple Innovation, Inc. Class A common stock $ Per Share

Table of Contents As filed pursuant to Rule 424(b)(5) Registration No. 333-269005 The information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are part of an effective registration statement filed with the Securities and Exchange Commission under the Securities Act of 1933. This preliminary pros

Purple Innovation Announces Preliminary Estimated Fiscal 2022 Results in Conjunction with Presenting its New Premium Mattress Lineup at Las Vegas Market

Exhibit 99.1 Purple Innovation Announces Preliminary Estimated Fiscal 2022 Results in Conjunction with Presenting its New Premium Mattress Lineup at Las Vegas Market Lehi, Utah, January 30, 2023 – Purple Innovation, Inc. (NASDAQ: PRPL) (“Purple” or the “Company”), a comfort innovation company known for creating the “World’s First No Pressure ™ Mattress,” today announced preliminary estimated resul

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 30, 2023 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Em

PURPLE INNOVATION, INC.

PURPLE INNOVATION, INC. January 27, 2023 VIA EDGAR United States Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Purple Innovation, Inc.—Registration Statement on Form S-3 (File No. 333-269005) Ladies and Gentlemen: Purple Innovation, Inc. respectfully withdraws its request for acceleration of the effectiveness of the Registration Stat

PURPLE INNOVATION, INC.

PURPLE INNOVATION, INC. January 27, 2023 VIA EDGAR United States Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Purple Innovation, Inc.—Registration Statement on Form S-3 (File No. 333-269005) Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective

As filed with the Securities and Exchange Commission on January 27, 2023

Amendment No. 1 Table of Contents As filed with the Securities and Exchange Commission on January 27, 2023 Registration No. 333-269005 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 PURPLE INNOVATION, INC. (Exact name of registrant as specified in its charter) Delaware 47-4078206 (State or

PURPLE INNOVATION, INC.

PURPLE INNOVATION, INC. January 26, 2023 VIA EDGAR United States Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Purple Innovation, Inc.—Registration Statement on Form S-3 (File No. 333-269005) Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective

Purple Innovation Special Committee of the Board Comments on Coliseum Capital Management’s Amended 13D

Exhibit 99.1 Purple Innovation Special Committee of the Board Comments on Coliseum Capital Management’s Amended 13D LEHI, Utah, January 19, 2023 /PRNewswire/ - Purple Innovation, Inc. (NASDAQ: PRPL), a comfort innovation company known for creating the “World’s First No Pressure® Mattress,” today responded to the amended Schedule 13D filed with the Securities and Exchange Commission by Coliseum Cap

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 19, 2023 Purple Innovatio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 19, 2023 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Em

COLISEUM CAPITAL MANAGEMENT, LLC

EX-99.1 2 d432418dex991.htm EX-99.1 Exhibit 99.1 COLISEUM CAPITAL MANAGEMENT, LLC DELIVERED VIA EMAIL January 13, 2023 Purple Innovation, Inc. 4100 North Chapel Ridge Road, Suite 200 Lehi, UT 94043 Attn: Mr. Paul Zepf, Chairman of the Board of Directors Dear Paul: We were disappointed by the announcement yesterday that Purple Innovation, Inc. (“Purple”, “you” or the “Company”) was rejecting our pr

PRPL / Purple Innovation Inc / Coliseum Capital Management, LLC - SC 13D/A Activist Investment

SC 13D/A 1 d432418dsc13da.htm SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 24)* PURPLE INNOVATION, INC. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 74640Y 106 (CUSIP Number) Christopher Shackelton/Adam Gray 105 Rowayton Avenue Rowayton, CT 06853 with a

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 9, 2023 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Emp

PRPL / Purple Innovation Inc / SCHWARTZ INVESTMENT TRUST Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Purple Innovation, Inc.

Form of subordinated indenture to be entered into between the Registrant and the trustee designated therein

EX-4.5 3 d428403dex45.htm EX-4.5 EXHIBIT 4.5 PURPLE INNOVATION, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of , 20 Subordinated Debt Securities Table of Contents Page ARTICLE 1 DEFINITIONS 1 Section 1.01 Definitions of Terms 1 ARTICLE 2 ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES 4 Section 2.01 Designation and Terms of Securities 4 Section 2.02 Form of

As filed with the Securities and Exchange Commission on December 23, 2022

S-3 Table of Contents As filed with the Securities and Exchange Commission on December 23, 2022 Registration No.

Filing Fee Table

Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Purple Innovation, Inc.

Form of senior indenture, to be entered into between the Registrant and the trustee designated therein

EX-4.3 2 d428403dex43.htm EX-4.3 EXHIBIT 4.3 PURPLE INNOVATION, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of , 20 Senior Debt Securities Table of Contents Page ARTICLE 1 DEFINITIONS 1 Section 1.01 Definitions of Terms 1 ARTICLE 2 ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES 4 Section 2.01 Designation and Terms of Securities 4 Section 2.02 Form of Secur

Second Amended and Restated Bylaws

Exhibit 3.1 SECOND AMENDED AND RESTATED BYLAWS OF PURPLE INNOVATION, INC. A DELAWARE CORPORATION (THE “CORPORATION”) (FORMERLY KNOWN AS GLOBAL PARTNER ACQUISITION CORP.) ARTICLE I OFFICES Section 1.1. Registered Office. The registered office of the Corporation within the State of Delaware shall be located at either (a) the principal place of business of the Corporation in the State of Delaware or

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 12, 2022 Purple Innovati

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 12, 2022 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS E

Performance Share Unit Agreement between the Company and Keira Krausz dated November 11, 2022*

Exhibit 99.2 Purple Innovation, Inc. INDUCEMENT GRANT Performance Share Unit Agreement Purple Innovation, Inc., a Delaware corporation (the “Company”), hereby grants to Participant identified below, as of the below Date of Grant, the right to receive shares of Class A common stock, par value $0.0001 per share, in an amount initially equal to the Target Number of Shares specified below on the terms

Filing Fee Table*

EX-FILING FEES 6 ea168454ex-feepurple.htm FILING FEE TABLE Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) Purple Innovation, Inc. (Exact name of registrant as specified in its charter) Table 1 – Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) (2) Proposed Maximum Offering Price Per Unit(3) Maximum Aggregate Offering Price

As filed with the Securities and Exchange Commission on November 11, 2022

As filed with the Securities and Exchange Commission on November 11, 2022 Registration No.

Offer Letter, dated as of October 15, 2022, signed by Keira Krausz*

Exhibit 99.1 October 13th, 2022 Dear Keira, On behalf of Purple Innovation, LLC (“Purple” or the “Company”), it is my pleasure to extend to you this written offer outlining the mutually agreed upon terms of your employment. Key points for your employment and compensation include: Position: Your position will be Chief Marketing Officer reporting to Rob DeMartini, Chief Executive Officer. It is anti

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2022 ☐ TRANSITION REPORT PURSUANT T

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-37523 PURPLE INNOVATION, INC.

Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2022 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State of Incorporation) (Commission File Number) (IRS Em

Purple Innovation Reports Third Quarter 2022 Results

Exhibit 99.1 Purple Innovation Reports Third Quarter 2022 Results Lehi, Utah, November 9, 2022 ? Purple Innovation, Inc. (NASDAQ: PRPL) (?Purple?), a comfort innovation company known for creating the ?World?s First No Pressure ? Mattress,? today announced results for the third quarter ended September 30, 2022. Third Quarter Financial Summary (Comparisons versus Third Quarter 2021 and Second Quarte

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2022 Purple Innovatio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2022 Purple Innovation, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 001-37523 47-4078206 (State or other jurisdiction of incorporation) (Commissio

SEPARATION AGREEMENT AND GENERAL RELEASE

Exhibit 99.1 SEPARATION AGREEMENT AND GENERAL RELEASE This Separation Agreement and General Release (hereinafter “Agreement”) is entered into as of the Effective Date (as defined in Section 16 of this Agreement), by and between Patrice Varni (hereinafter “Employee”), on the one hand, and Purple Innovation, LLC, a Delaware limited liability company (hereinafter “Employer”), on the other hand. RECIT

Purple Appoints Keira Krausz as Chief Marketing Officer Krausz Brings Significant Marketing Experience and a Track Record of Growing Revenue & EBITDA

Exhibit 99.1 Purple Appoints Keira Krausz as Chief Marketing Officer Krausz Brings Significant Marketing Experience and a Track Record of Growing Revenue & EBITDA Lehi, Utah, October 18, 2022 – Purple Innovation, Inc. (NASDAQ: PRPL) (“Purple”), a comfort innovation company known for creating the “World’s First No Pressure® Mattress,” today announced the appointment of Keira Krausz as its Chief Mar

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 18, 2022 Purple Innovatio

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 18, 2022 Purple Innovation, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37523 47-4078206 (State or other jurisdiction of incorporation) (Commissio